21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
FIBER SATIETY COMPOSITIONS
#10802Composition comprising polyunsaturated fatty acids and activated charcoal
#10803METHOD AND PREPARATIONS FOR TREATING INFECTION-ALLERGIC DISEASES
#10804Method of treatment using checkpoint kinase 1 inhibitors
#10805Methods and compositions for the prevention and treatment of inflammatory diseases
#10806Treatment or prevention of cancer and precancerous disorders
#10807Enzyme delivery systems and methods of preparation and use
#10808Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
#10809Kits for nutrition supplementation
#10810Abuse-deterrent drug formulations
#10811ABUSE-PROOFED DOSAGE FORM
#10812COMBINATION THERAPY FOR OVARIAN CANCER
#10813NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY
#10814Modulation of platelet aggregation
#10815PAI-1 BINDING MODULATORS FOR THE TREATMENT OF OCULAR DISORDERS
#10816Treatment methods for autoimmune disorders
#10817THERAPEUTIC METHOD FOR REDUCING ANGIOGENESIS
#10818Composition and Method for Treating Inflammatory Disorders
#10819USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
#10820IBUDILAST AND IMMUNOMODULATORS COMBINATION
#10821AMINOFLAVONE (NSC 686288) AND COMBINATIONS THEREOF FOR TREATING BREAST CANCER
#10822COMBINATION BETWEEN AN ISOTHIOCYANATE AND LEVODOPA FOR PARKINSON'S DISEASE TREATMENT
#10823Anti aging agents and methods to identify them
#10824ROLE FOR SRY IN PARKINSON'S DISEASE
#10825IMPLANTABLE SYSTEM FOR AN INTERVERTEBRAL DISC AND INTERVERTEBRAL DISC IMPLANT
#10826Prevention of opportunistic infections in immune-compromised subjects
#10827Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
#10828Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
#10829Hepatitis C virus inhibitors
#10830Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
#10831USE OF HUMAN ANTIBODY CAPABLE OF NEUTRALIZING HEPATITIS B VIRUS FOR THE PREVENTION OR TREATMENT OF HEPATITIS B VIRUS INFECTION
#10832MOUTHWASH COMPOSITION COMPRISING XANTHAN GUM AND SODIUM FLUORIDE
#10833NOVEL BONE MASS INCREASING AGENT
#10834ANTI-IGF-I RECEPTOR ANTIBODIES
#10835Method for treating atypical facial pain
#10836Potentiating the effect of compound comprising nitric oxide
#108371-BUTANE ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THE USE THEREOF
#10838Angiogenesis inhibitor
#10839Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
#10840AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR EPILEPSY
#10841Methods of and compositions for reducing cell death
#10842BORON-CONTAINING SMALL MOLECULES
#10843Unique combinations of antimicrobial compositions
#10844ORGAN PROTECTION, PRESERVATION AND RECOVERY
#10845Compositions and methods related to calcitriol
#10846ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
#10847Antibodies to insulin-like growth factor I receptor
#10848Edible mix and method of making the same
#10849HERBAL COMPOSITION PHY906 AND ITS USE IN CHEMOTHERAPY
#10850Avian feed composition
#10851AROMATASE INHIBITOR
#10852Medicament for treatment of cancer and other diseases
#10853EDIBLE GELATIN BOWEL PREPARATION AND BOWEL CLEANSING METHOD
#10854Mucositis Prevention Supplement and Treatment
#10855ORAL ZINC MEDICANTS USEFUL FOR SAFELY LOWERING FREE COPPER ABSORPTION AND FREE COPPER LEVELS
#10856HERBAL COMPOSITION FOR TREATMENT OF NEURODEGENERATION AND NEURONAL DYSFUNCTION
#10857Combination treatment of cancer with cetuximab and tetrac
#10858Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease
#10859Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
#10860Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS
#10861Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of , and methods of preparation thereof
#10862Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases
#10863Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
#10864Compositions and methods for modulating the activity of complement regulatory proteins on target cells
#10865Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
#10866ANTI-NGF ANTIBODIES FOR THE TREATMENT OF VARIOUS DISORDERS
#10867Engineered anti-alpha V-integrin hybrid antibodies
#10868NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
#10869Pharmaceutical preparation for treating benign prostatic hyperplasia
#10870TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE II
#10871Probiotic bacteria and regulation of fat storage
#10872Nerve Regeneration Promoting Agent
#10873HEPATITIS C ANTIVIRAL COMPOSITIONS AND METHODS
#10874INTERLEUKIN-18 BINDING PROTEINS, THEIR PREPARATION AND USE FOR THE TREATMENT OF SEPSIS
#10875Compositions and Methods for Regulating an Immune Response in a Subject
#10876Formulation having mobilising activity
#10877Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
#10878Ophthalmic compositions comprising povidone-iodine
#10879Topical Turmeric Skin Care Products
#10880Compounds that inhibit (block) bitter taste in composition and use thereof
#10881Inhibitors of Bruton's tyrosine kinase
#10882Transdermal venous access locking solution
#10883Drug delivery system for accelerated subcutaneous absorption
#10884METHOD OF REDUCING NEURONAL CELL DAMAGE
#10885Non-steroidal anti-inflammatory drug dosing regimen
#10886Compositions containing zinc salts for coating medical articles
#10887Methods of treating skin with aromatic skin-active ingredients
#10888Cancer Treatment Method
#10889Stable pharmaceutical composition of freeze-dried tetrodoxin powder
#10890Heteroaryloxy quinazoline derivative
#10891ORGANIC COMPOUNDS
#10892Compositions and Methods for Treating Intoxications
#10893COMBINATION OF CHK AND PARP INHIBITORS FOR THE TREATMENT OF CANCERS
#10894Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
#10895COMBINATION TREATMENT
#10896NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR
#10897BETA GLYCOLIPIDS FOR THE TREATMENT OF CALCIFICATION RELATED DEGENERATIVE DISORDERS
#10898Alpha-fetoprotein peptides and uses thereof
#10899Nutritional Composition Comprising Curcuminoids and Methods of Manufacture
#10900ANTI-MITOTIC AGENT AND AURORA KINASE INHIBITOR COMBINATION AS ANTI-CANCER TREATMENT
#10901Oral composition
#10902CRF CONJUGATES WITH EXTENDED HALF-LIVES
#10903CETP inhibitors
#10904ISOFLAVONE FORMULATION
#10905USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#10906In-vitro method for testing bioequivalence of iron-sucrose formulation
#10907Methods and compositions for modulating RAD51 and homologous recombination
#10908Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
#10909Methods for making nutritional compositions comprising curcuminoids
#10910Hop acids as a replacement for antibiotics in animal feed
#10911COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA
#10912Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
#10913Anti-angiogenic agents and anti-obesity substances applied with anti-angiogenesis from natural products
#10914Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
#10915FORMULATION FOR TATTOO REMOVAL AND METHOD OF USING SAME
#10916Methods For Treating and Reducing the Incidence of Newcastle Disease
#10917Use of nitrite salts for the treatment of cardiovascular conditions
#10918Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes
#10919Compositions and Methods to Modulate Angiogenesis
#10920METHODS AND COMPOSITIONS FOR ALTERING CELL FUNCTION
#10921Compositions and methods for treatment of hemorrhage
#10922Thyroid protection in sickle cell anemia treatment
#10923PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE
#10924PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN
#10925Solid oral dosage form containing an enhancer
#10926Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
#10927Compositions and methods for inhibiting gastric acid secretion
#10928Skin treatment compositions containing copper-pigment complexes
#10929Orally bioavailable lipid-based constructs
#10930TREATMENT REGIME FOR PROLIFERATIVE DISORDERS
#10931Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product
#10932METHOD OF REDUCING THE EFFECTS OF CYTOSTATIC DRUGS ON BONE MARROW DERIVED CELLS, AND METHODS OF SCREENING
#10933Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
#10934THERAPEUTIC AGENT FOR CANCER
#10935Topical skin care formulations
#10936Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist
#10937Compositions and methods for promoting the healing of tissue of multicellular organisms
#10938Methods and Compositions For Modulating Angiogenesis
#10939Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramide
#10940TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECAN
#10941Method for the treatment of rheumatoid arthritis using a TLR2 antagonistic antibody
#10942Thrombin-like enzyme for reducing a side effect of an anticancer drug
#10943Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and/or C-reactive protein in blood
#10944Foodstuff comprising an extract of a plant of the genus and flavonoid
#10945Potentiation of Stem Cell Homing and Treatment of Organ Dysfunction or Organ Failure
#10946COMBINATION THERAPY OF AN AFUCOSYLATED ANTIBODY AND ONE OR MORE OF THE CYTOKINES GM CSF, M CSF AND/OR IL3
#10947Therapeutic agent composition and method of use
#10948Compositions for elastogenesis and connective tissue treatment
#10949COMPOSITION AND METHOD OF TREATING A SORE THROAT
#10950USE OF ERYTHROPOIETIN
#10951USE OF ERYTHROPOIETIN
#10952USE OF ERYTHROPOIETIN
#10953Mycobacterial immunotherapy for cancer treatment
#10954Methods of inhibiting cell growth and methods of enhancing radiation responses
#10955METHODS OF USING NITROXIDES IN CONJUNCTION WITH PHOTOSENSITIZERS AND SONOSENSITIZERS
#10956Therapeutic and cosmetic compositions for treatment of skin
#10957METHOD OF TREATMENT OF INFLAMMATION IN HYPERTENSIVE PATIENTS
#10958Anti-angiogenic nanoparticle compositions
#10959PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS
#10960Compositions and methods for angiogenic therapy utilizing genes encoding ets-1
#10961SYNTHESIS OF EPOTHILONES, INTERMEDIATES THERETO, ANALOGUES AND USES THEREOF
#10962PHARMACEUTICAL COMPOSITION FOR TREATING OVERACTIVE BLADDER
#109631′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-[1,4′] bipyridinyl-2′-ones
#10964Minoxidil aqueous composition containing bile acid
#10965COMBINATION THERAPY, COMPOSITION AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
#10966COMBINATION OF CHECKPONIT KINASE (CHK) AND TELANGIECTASIA MUTATED (ATM) INHIBITORS FOR THE TREATMENT OF CANCER
#10967Skin treatments
#10968COMPOSITION AND METHODS RELATING TO GLUCOCORTICOID RECEPTOR-ALPHA AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
#10969Antiemetic-oral contraceptive combination
#10970TOPICAL PHARMACEUTICAL COMPOSITION FOR THE COMBINATION OF FUSIDIC ACID AND A CORTICOSTEROID
#10971Substituted piperazines
#10972NOVEL LIPID COMPOUNDS
#10973Dextrin-containing composition for preventing surgical adhesions
#10974NOVEL IMMUNOTHERAPY STRATEGY
#10975METHODS AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS
#10976ANTIOXIDANT CONSTITUENTS
#10977REPAIR OF RUPTURED MEMBRANE BY INJECTION OF NATURALLY OCCURRING PROTEIN IN AMNIOTIC FLUID SAC
#10978Improved Antitumoral Treatments
#10979Compound for use in the treatment of peripheral neuropathies
#10980IN VIVO CELL SURFACE ENGINEERING
#10981Blackberry leaf extract as an active ingredient against skin irritations and inflammations
#10982Cannabinoid-containing plant extracts as neuroprotective agents
#10983COMPOSITION FOR ORAL CAVITY AND SKIN
#10984Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
#10985COLONIC DELIVERY OF ANTIMICROBIAL AGENTS
#10986Combinations of statins and anti-obesity agent
#10987PHARMACEUTICAL NIMODIPINE COMPOSITIONS
#10988IMMUNOLIPOSOMES FOR TREATMENT OF CANCER
#10989Methods and compositions for wound healing
#10990Warming vapor pad
#10991Compositions and methods for promoting bone formation
#10992PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
#10993Combinations of botanical extracts for promoting cardiovascular health
#10994Amino ester derivatives, sailts thereof and methods of use
#10995PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL DISEASES
#10996Methods for promoting cellular health and treatment of cancer
#10997Combination Therapies for Treating Metabolic Disorders
#10998Hybrid proteins that migrate retrogradely and transynaptically into the CNS
#10999PEG-interferon-beta formulations
#11000Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta
#11001TLR MODULATORS AND METHODS FOR USING THE SAME
#11002Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway
#11003DRY-POWDER MEDICAMENT
#11004Methods and compositions for facilitating arterial access
#11005Reproductive management
#11006Composition and method to modify sperm function and increase male gender ratio in mammals
#11007METHODS FOR IMPROVING BIOAVAILABILITY OF A RENIN INHIBITOR
#11008Administration of intravenous ibuprofen
#11009Compositions for improved oxidative status in companion animals
#11010Immunostimulatory method
#11011Combinations of statins and anti-obesity agent
#11012Compositions and Methods for Treatment and Prevention of Cardiovascular Disease
#11013Phenylpropionamide compounds and the use thereof
#11014COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS
#11015New Combination for the Treatment of Respiratory Diseases
#11016PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF NEUROFIBROMATOSIS
#11017USE OF A VASOPEPTIDASE INHIBITOR FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#11018COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR
#11019Substituted indole derivatives for the treatment of respiratory diseases
#11020Pyridazinone derivatives
#11021PHARMACEUTICAL COMBINATIONS OF A NICOTINE RECEPTOR MODULATOR AND A COGNITIVE ENHANCER
#11022SILVER(I) COMPOUNDS AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT,PROPHYLAXIS AND PREVENTION OF INFECTIONS
#11023Quinuclidine derivatives and medicinal compositions containing the same
#11024Use of difructose anhydride-containing composition
#11025Treating alzheimer's disease and osteoporosis and reducing aging
#11026PROPHYLACTIC AND/OR THERAPEUTIC AGENTS FOR PERIPHERAL NEUROPATHY
#11027Delivery of a light-activated cation channel into the brain of a subject
#11028Isoxazolines for controlling invertebrate pests
#11029GRAPE POLYPHENOLICS FOR PLATELET AND BACTERIAL CONTROL
#11030COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS
#11031SYSTEMIC ADMINISTRATION OF NAC AS AN ADJUNCT IN THE TREATMENT OF TERRORISM EXPOSURES SUCH AS RADIATION AND FOR PROPHYLAXIS
#11032Use of tellurium compounds for inhibition of interleukin-converting enzyme
#11033Animal lesion treatment and prevention formulations and methods
#11034Use of difructose anhydride-containing composition
#11035Method and composition for treatment of yeast infection through a radial appliance or a wet-cell battery appliance and solution jar set
#11036Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
#11037Pharmaceutical Composition Comprising Amlodipine and Losartan
#11038Pharmaceutical composition for oral administration
#11039SYNERGISTIC COMBINATIONS FOR TREATING HYPERTENSION
#11040Combination of triazine derivatives and insulin secretion stimulators
#11041Dressing Material Comprising Active Substances
#11042COMBINATION ENZYME FOR CYSTIC FIBROSIS
#11043USE OF MICROVESICLES (MVS) FOR PREPARING A MEDICAMENT HAVING ADJUVANT ACTIVITY ON ENDOTHELIAL CELL TRANSPLANTATION, PARTICULARLY IN THE TREATMENT OF DIABETES BY PANCREATIC ISLET TRANSPLANTATION, AND RELATED METHOD
#11044USE OF OLIGOSACCHARIDES CONTAINING N-ACETYLLACTOSAMINE FOR MATURATION OF IMMUNE RESPONSES IN NEONATES
#11045TREATMENT OF NEOVASCULAR OCULAR DISEASE STATES
#11046SYSTEMIC ADMINISTRATION OF NAC FOR VACCINATION PROPHYLAXIS
#11047Antibodies against toxins and uses thereof
#11048Antibodies against clostridium difficile toxins and uses thereof
#11049IDO inhibitors and methods of use
#11050Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
#11051Methods of treating stroke and traumatic brain injury using humanized AQC2 anti-VLA-1 antibodies
#11052INDUCTION OF IMMUNE TOLERANCE
#11053REDUCTION OF ADIPOSE TISSUE
#11054Injection of fibrin sealant including an anesthetic in spinal applications
#11055COMPOSITION USED AS A NUTRITIONAL SUPPLEMENT AND MEDICATION FOR THE TREATMENT OF DEGENERATIVE VISUAL DISORDERS AND INFLAMMATION
#11056PREVENTION AND TREATMENT OF SECONDARY INFECTIONS FOLLOWING VIRAL INFECTION
#11057Natural Skin Products Containing Dairy and Processes
#11058METHOD FOR TREATING MULTIPLE SCLEROSIS
#11059Suppression of immune response to factor VIII in hemophilia A patients
#11060Use of WF10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
#11061GASTROPOD BIOLOGICAL FLUID, METHOD OF MAKING AND REFINING AND USE
#11062Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#11063Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs
#11064Energy absorbing thermoplastic elastomer
#11065Elastomeric gloves and methods of making
#11066METHOD AND APPARATUS FOR THE DEACTIVATION OF BACTERIAL AND FUNGAL TOXINS IN WOUNDS, AND FOR THE DISRUPTION OF WOUND BIOFILMS
#11067Treatment of microbial infections with compounds that inhibit 4-hydroxyphenylpyruvate dioxygenase
#11068Transdermal compositions
#11069Non-steroidal anti-inflammatory ophthalmic compositions
#11070METHOD FOR TREATING EQUINE LAMINITIS
#11071Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
#11072Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
#11073Methods of Reducing Side Effects of Analgesics
#11074Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
#110755-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
#11076Oral Pharmaceutical Formulations Containing Non-Steroidal Anti-Inflammatory Drugs and Acid Inhibitors
#11077Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
#11078METHODS FOR PREVENTING AND TREATING MICROBIAL INFECTIONS BY MODULATING TRANSCRIPTION FACTORS
#11079CANNABINOID-1 RECEPTOR MODULATORS USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#11080Modulation of telomere length in telomerase positive cells and cancer therapy
#11081Synergistic phytochemical composition for the treatment of obesity
#11082PHARMACEUTICAL COMPOSITIONS
#11083SIMULTANEOUS PHOTODYNAMIC THERAPY AND PHOTO INDUCED POLYMERIZATION
#11084USE OF THE STAUDINGER LIGATION IN IN VIVO ASSEMBLY OF A BIOLOGICALLY ACTIVE COMPOUND
#11085Phospholipid and protein tablets
#11086Compounds having antitumor activity
#11087Method For Generating and Selecting Antibodies Against Target Protein
#11088Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
#11089Self-Preserving Compositions
#11090Antioxidant compositions comprising extracts of myrtle and rosemary
#11091METHOD OF DELIVERING NUTRIENTS
#11092ANTI-VIRAL AND ANTI-MICROBIAL DENTAL OPERATIVE MATERIAL AND METHODS
#11093Compositions and methods of delivery of pharmacological agents
#11094NOVEL TABLET BASED ON S-ADENOSYL-METHIONINE
#11095TRANSDERMAL PAIN GEL
#11096Topical agent for muscle treatment
#11097Plant extract compositions for prevention and treatment of influenza
#11098SPECIFIC PROTEASE INHIBITORS AND THEIR USE IN CANCER THERAPY
#11099Antitumoral Treatments
#11100METHODS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES